Literature DB >> 20031084

Using cancer registry data: agreement in cause-of-death data between the Ontario Cancer Registry and a longitudinal study of breast cancer patients.

D R Brenner1, M C Tammemägi, S B Bull, D Pinnaduwaje, I L Andrulis.   

Abstract

Data from the Ontario Cancer Registry (OCR) were compared with data from a multi-centred prospective cohort of 1655 node-negative breast cancer patients with intensive clinical follow-up. Agreement in cause of death was evaluated using kappa statistics. The accuracy of OCR classification was evaluated against the Mount Sinai Hospital (MSH) study oncologist's interpretation of intensely followed, cohort-collected data as the reference standard. The two sources showed a high level of agreement (kappa statistic [kappa] = 0.88; 95% confidence interval [CI]: 0.86, 0.90) in vital status and cause of death. Among those cases where both sources reported a death, the OCR had a sensitivity of 95% (95% CI: 90.5, 98.8) and a specificity of 88% (95% CI: 79.6, 92.4). The OCR is a valuable tool for epidemiologic studies of breast cancer to acquire adequate and easily attainable cause-of-death information.

Entities:  

Mesh:

Year:  2009        PMID: 20031084

Source DB:  PubMed          Journal:  Chronic Dis Can        ISSN: 0228-8699


  14 in total

1.  A population-based study of the epidemiology of pancreatic cancer: a brief report.

Authors:  R S Raju; N Coburn; N Liu; J M Porter; S J Seung; M C Cheung; N Goyert; N B Leighl; J S Hoch; M E Trudeau; W K Evans; K N Dainty; C C Earle; N Mittmann
Journal:  Curr Oncol       Date:  2015-12       Impact factor: 3.677

2.  Metformin and breast cancer stage at diagnosis: a population-based study.

Authors:  I C Lega; K Fung; P C Austin; L L Lipscombe
Journal:  Curr Oncol       Date:  2017-04-27       Impact factor: 3.677

3.  Diabetes and kidney cancer outcomes: a propensity score analysis.

Authors:  Madhur Nayan; Antonio Finelli; Michael A S Jewett; David N Juurlink; Peter C Austin; Girish S Kulkarni; Robert J Hamilton
Journal:  Endocrine       Date:  2016-11-04       Impact factor: 3.633

4.  Polysomnographic Markers of Obstructive Sleep Apnea Severity and Cancer-related Mortality: A Large Retrospective Multicenter Clinical Cohort Study.

Authors:  Tetyana Kendzerska; Andrea S Gershon; Marcus Povitz; Mark I Boulos; Brian J Murray; Daniel I McIsaac; Gregory L Bryson; Robert Talarico; John Hilton; Atul Malhotra; Richard S Leung
Journal:  Ann Am Thorac Soc       Date:  2022-05

5.  Solid Organ Transplantation in Patients With Preexisting Malignancies in Remission: A Propensity Score Matched Cohort Study.

Authors:  Sergio A Acuna; Rinku Sutradhar; S Joseph Kim; Nancy N Baxter
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

6.  Obstructive sleep apnea and the prevalence and incidence of cancer.

Authors:  Tetyana Kendzerska; Richard S Leung; Gillian Hawker; George Tomlinson; Andrea S Gershon
Journal:  CMAJ       Date:  2014-08-05       Impact factor: 8.262

7.  Obstructive Sleep Apnea and Incident Cancer: A Large Retrospective Multicenter Clinical Cohort Study.

Authors:  Tetyana Kendzerska; Marcus Povitz; Richard S Leung; Mark I Boulos; Daniel I McIsaac; Brian J Murray; Gregory L Bryson; Robert Talarico; John F Hilton; Atul Malhotra; Andrea S Gershon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-12-02       Impact factor: 4.090

8.  Vasectomy and risk of prostate cancer: population based matched cohort study.

Authors:  Madhur Nayan; Robert J Hamilton; Erin M Macdonald; Qing Li; Muhammad M Mamdani; Craig C Earle; Girish S Kulkarni; Keith A Jarvi; David N Juurlink
Journal:  BMJ       Date:  2016-11-03

9.  Association between metformin therapy and mortality after breast cancer: a population-based study.

Authors:  Iliana C Lega; Peter C Austin; Andrea Gruneir; Pamela J Goodwin; Paula A Rochon; Lorraine L Lipscombe
Journal:  Diabetes Care       Date:  2013-04-30       Impact factor: 19.112

10.  Is pathology necessary to predict mortality among men with prostate-cancer?

Authors:  David Margel; David R Urbach; Lorraine L Lipscombe; Chaim M Bell; Girish Kulkarni; Jack Baniel; Neil Fleshner; Peter C Austin
Journal:  BMC Med Inform Decis Mak       Date:  2014-12-12       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.